![]() |
Volumn 50, Issue 9-10, 2007, Pages 927-932
|
From ICI to AstraZeneca: The development of synthetic isotope chemistry at Alderley Park, UK
|
Author keywords
Isotopic labelling; Pharmaceuticals; Synthesis
|
Indexed keywords
DRUG PRODUCTS;
ASTRA ZENECA;
CANDIDATE DRUGS;
ISOTOPIC LABELING;
ISOTOPICALLY LABELED;
PHARMACEUTICAL INDUSTRY;
SYNTHESISED;
ISOTOPES;
1 NAPHTHOL;
ANASTROZOLE;
ANTIESTROGEN;
AROMATASE INHIBITOR;
AZD 3409;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BICALUTAMIDE;
CARBON 13;
CARBON 14;
CHLORHEXIDINE;
CHLORHEXIDINE GLUCONATE;
CLOFIBRATE;
DEUTERIUM;
DRUG RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
FULVESTRANT;
GEFITINIB;
GOSERELIN;
IODINE 125;
ISOTOPE;
NITROGEN 15;
PENICILLIN DERIVATIVE;
PROPRANOLOL;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
RADIOISOTOPE;
RADIOPHARMACEUTICAL AGENT;
SULFUR 35;
TAMOXIFEN;
TAMOXIFEN CITRATE;
TRITIUM;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ARTICLE;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
ISOTOPE LABELING;
RADIOCHEMISTRY;
|
EID: 35748960484
PISSN: 03624803
EISSN: 10991344
Source Type: Journal
DOI: 10.1002/jlcr.1423 Document Type: Article |
Times cited : (3)
|
References (20)
|